peramivir failed in a clinical trial, page-6

I don't know what to make of this.

http://www.chinadaily.com.cn/china/2009-05/09/content_7759952.htm

Yan Jiangying is a spokeswoman with the State Food and Drug Administration (SFDA)



Moreover, Yan said China has sufficient stocks of anti-flu drugs, but declined to elaborate.

The WHO recommended two antiviral drugs for the flu: Tamiflu made by Roche and Relanza produced by GlaxoSmithKline.

Tamiflu had been permitted to enter the Chinese market, but Relanza is still undergoing clinical trials, she said. However, the SFDA will allow the temporary importation of Relanza.

Domestic scientists also have been developing a new antiviral injection, Peramivir Trihydrate, which is expected to tackle the new flu strain, she said.


Relenza still undergoing trails?
Domestic scientists developing peramivir?